Congratulations to our Global Top Performer for September 2024 - Ewan Rennison! Ewan reached an amazing 568% of his monthly target - what an achievement! #topperformer #recruitmentlondon #pharmarecruitment
Mantell Associates
Executive Search Services
City of London, England 91,032 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
150 Minories
City of London, England EC3N 1LS, GB
-
2 S Biscayne Blvd
Miami, Florida 33131, US
-
Rigistrasse 3
Zug, 6300, CH
Employees at Mantell Associates
Updates
-
Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds. Read more below: https://lnkd.in/e2rGbeUz #therapeutics #pharmafunding #biotechnews
-
A big thank you to Jay Lefley as he celebrates one year at Mantell Associates! Jay joined MA in October 2023, and has since become an valued part of our Contract team. He has secured our biggest contract deal ever, while building a solid client and contractor base across the Clinical Operations space. Congratulations on your one year anniversary Jay - here's to the next! #workanniversary #recruitmentteam #recruitmentlondon
-
BioAI, an emerging biotech company applying multimodal AI to novel biomarker discovery, development, and diagnostics, has partnered with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers. Read more below: https://lnkd.in/ejR-Q3CQ #ai #clinicaltrials #biomarkers
BioAI, Arbele Partner to Advance Predictive AI Models in Oncology Clinical Trials
contractpharma.com
-
Conor O'Shea explores how the cell and gene therapy industry is undergoing a transformative shift, with a rise in cutting-edge treatments like CRISPR-based therapies. Vertex Pharmaceuticals’ partnership with Lonza aims to bolster the production of their CRISPR therapy, Casgevy, which represents a major breakthrough in treating genetic diseases like sickle cell disease. Read more below: https://lnkd.in/eFKV8XXs #genetherapy #crisprtherapy #cellandgene
Rise in Cutting-Edge CRISPR-Based Therapies: Vertex & Lonza
https://www.mantellassociates.com
-
Genentech is paying $850 million upfront for Regor Therapeutics Group's portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in patients failed by existing options. Read more below: https://lnkd.in/eQYS9mD5 #breastcancer #cancertreatment #regenerativemedicine
Roche celebrates Pharma Day by buying Regor's CDK inhibitors, regenerative med-focused AntlerA
fiercebiotech.com
-
Huge congratulations to Ewan Rennison who has been promoted to Managing Associate! Ewan joined the MA team back in April 2021 and since then has built a strong network within the CDMO sector across Europe, APAC and the USA. In his new role as Managing Associate, Ewan will continue to oversee and develop his team working in the Commercial space. Congratulations Ewan - well deserved and we look forward to your continued success! #promotion #recruitment #recruitmentlondon
-
Piramal Pharma Solutions, a global CDMO, is investing $80 million to expand its Lexington, KY facility. The site specializes in sterile compounding, liquid filling, and lyophilization for sterile injectable drug products, playing a vital role in Piramal’s integrated antibody-drug conjugate development and manufacturing program, ADCelerate. Read more below: https://lnkd.in/egEkUPxt #sterileinjectables #expansion #cdmonews
Piramal Pharma Solutions Plans $80M Sterile Injectables Facility Expansion
contractpharma.com
-
Tampa’s Moffitt Cancer Center is forging an international partnership with Japan’s largest CRO, CMIC Group, to improve the ability of both organizations to run global cancer trials. Read more below: https://lnkd.in/erHGq3M3 #cro #cancercenter #cropartnership
Tampa's Moffitt Cancer Center forms cancer trial partnership with Japan's largest CRO
fiercebiotech.com
-
With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential blockbuster in tow. Organon is set to acquire Roivant Sciences’ immuno-dermatology subsidiary Dermavant Sciences for up to $1.2 billion, the companies announced Wednesday. Under the terms of the deal—which is expected to close in the fourth quarter—Organon will dish out an upfront payment of $175 million. Read more below: https://lnkd.in/e8HUYDa2 #pharmaacquisition #investment #healthnews
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
fiercepharma.com